Arrowhead Pharmaceuticals, Inc. ARWR

@sonnyG I’ll listen to your other 20 haha. Anyway Arrowhead has been steamrolling would love to see triple digits soon enough.

$OBSV Analysts expect $16-$36 per share.

Shareholders will be ecstatic, with their stake up 30% over the past week following ObsEva SA‘s (NASDAQ:OBSV) latest quarterly results. Revenues came in 113% better than analyst models expected, at US$4.0kwhile statutory losses per share were US$0.48, in line with forecasts. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year

Emerging bios $RIGL $ARWR

Stocks to look at with huge potential $ARWR $VKTX $AXSM #CARA and most of all $RIGL with a strong buy $$$

Below 28 !! Sold all my position here. Not looking good.